-
Unraveling Chemoresistance Mechanisms and Developing Targeted Strategies in Pancreatic and Lung Cancers
Xu, G., 8 Apr 2026, 296 p.Research output: PhD thesis › Research HvA, graduation HvA (not in use)
-
Unraveling resistance mechanisms to the novel nucleoside analog RX-3117 in lung cancer: insights into DNA repair, cell cycle dysregulation and targeting PKMYT1 for improved therapy
Vahabi, M., Xu, G., Sarkisjan, D., Hassouni, B. E., Mantini, G., Donati, V., Wang, B., Lencioni, G., Honeywell, R. J., Deng, D., Strano, S., Peters, G. J., Blandino, G. & Giovannetti, E., 1 Dec 2025, In: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 44, 1, p. 1-19 19 p., 217.Research output: Contribution to journal › Article › Academic › peer-review
-
Novel Pyrazolo [1,5-a]−1,3,5-Triazine Derivatives as CDK7 Inhibitors: Synthesis and Biological Insights in Pancreatic Ductal Adenocarcinoma Models
Carbone, D., Terrana, F., Sciuto, L., Pecoraro, C., Xu, G., Cascioferro, S., Cirrincione, G., Peters, G. J., Giovannetti, E., Parrino, B. & Diana, P., 6 Oct 2025, In: CHEMMEDCHEM. 20, 19, e202500448.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
